| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AVEXIS INC COM | 1,035,657 | 42,679,000 | 21.91% | ||
| 2 | BIOCRYST PHARMACEUTICALS | 5,721,142 | 25,230,000 | 12.95% | ||
| 3 | EDGE THERAPEUTICS INC | 1,933,582 | 20,129,000 | 10.33% | ||
| 4 | DBV Technologies | 373,617 | 19,444,000 | 9.98% | ||
| 5 | Ascendis Pharma | 721,152 | 14,495,000 | 7.44% | ||
| 6 | CYTOMX THERAPEUTICS INC COM | 577,831 | 9,060,000 | 4.65% | ||
| 7 | Audentes Therapeutics, Inc. | 458,882 | 7,267,000 | 3.73% | ||
| 8 | HERON THERAPEUTICS INC | 405,901 | 6,994,000 | 3.59% | ||
| 9 | COLUCID PHARMACEUTICALS INC COM | 159,110 | 6,070,000 | 3.12% | ||
| 10 | AXOVANT SCIENCES LTD | 429,590 | 6,014,000 | 3.09% | ||
| 11 | REGENXBIO INC COM | 332,494 | 4,658,000 | 2.39% | ||
| 12 | ALCOBRA LTD | 1,537,463 | 3,798,000 | 1.95% | ||
| 13 | BEIGENE LTD | 119,000 | 3,666,000 | 1.88% | ||
| 14 | COHERUS BIOSCIENCES INC COM | 129,629 | 3,471,000 | 1.78% | ||
| 15 | STEMLINE THERAPEUTICS INC | 315,980 | 3,422,000 | 1.76% | ||
| 16 | ACHILLION PHARMACEUTICALS INC COM | 420,000 | 3,402,000 | 1.75% | ||
| 17 | AKARI THERAPEUTICS PLC | 369,490 | 3,144,000 | 1.61% | ||
| 18 | ARCA biopharma Inc | 1,078,932 | 3,053,000 | 1.57% | ||
| 19 | OCERA THERAPEUTICS INC | 1,088,372 | 2,873,000 | 1.47% | ||
| 20 | AEGLEA BIOTHERAPEUTICS INC COM | 350,133 | 2,235,000 | 1.15% | ||
| 21 | LIPOCINE INC NEW | 420,000 | 1,873,000 | 0.96% | ||
| 22 | ADVERUM BIOTECHNOLOGIES INC | 280,000 | 1,151,000 | 0.59% | ||
| 23 | ZAFGEN INC COM | 141,479 | 468,000 | 0.24% | ||
| 24 | ProNAi Therapeutics, Inc. | 130,798 | 238,000 | 0.12% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-022460, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
